You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

16-043

Showing 1 - 25 of 5,814
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Kidney Cancer, Kidney Cancer, Clear Cell Renal Cell Carcinoma Trial in United States (Guadecitabine, Durvalumab)

Active, not recruiting
  • Advanced Kidney Cancer
  • +2 more
  • Chicago, Illinois
  • +4 more
Feb 16, 2022

Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +3 more
Jun 22, 2023

Pulmonary Tuberculosis Trial (GSK3036656, BTZ-043, Bedaquiline (B))

Not yet recruiting
  • Pulmonary Tuberculosis
  • (no location specified)
Oct 27, 2023

Chronic Cough Trial in Worldwide (Gefapixant, Placebo)

Completed
Has Results
  • Chronic Cough
  • Phoenix, Arizona
  • +90 more
Sep 19, 2022

Wounds and Injuries Trial in Czechia, Denmark, United States (LNA043, Placebo)

Completed
  • Wounds and Injuries
  • LNA043
  • Placebo
  • Phoenix, Arizona
  • +18 more
Jan 24, 2023

Phenylketonurias Trial in Reutlingen (PKU Sphere)

Active, not recruiting
  • Phenylketonurias
  • PKU Sphere
  • Reutlingen, Baden-Württemberg, Germany
    Kreiskliniken Reutlingen
Sep 15, 2022

Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug

Completed
  • Pulmonary Tuberculoses
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +1 more
Aug 9, 2022

Epilepsy Trial in Worldwide (Placebo, Brivaracetam, Antiepileptic drugs with market authorization available per country)

Completed
Has Results
  • Epilepsy
  • Placebo
  • +2 more
  • Phoenix, Arizona
  • +206 more
Jul 14, 2022

Tuberculosis, Tuberculosis, Pulmonary, Bacterial Infections Respiratory Trial in Groningen (500mg BTZ-043 containing 3.7 MBq of

Completed
  • Tuberculosis
  • +4 more
  • 500mg BTZ-043 containing 3.7 MBq of [14C]BTZ-043
  • Groningen, Netherlands
    PRA Health Sciences (PRA) - Early Development Services (EDS)
Oct 19, 2021

Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Charleston (ADVM-043)

Completed
Has Results
  • Alpha 1-Antitrypsin Deficiency
  • ADVM-043
  • Gainesville, Florida
  • +1 more
Aug 3, 2022

COVID-19 Trial (GLB-COV2-043, BNT162b2/COMIRNATY®)

Not yet recruiting
  • COVID-19
  • (no location specified)
Oct 31, 2022

Hypogonadotropic Hypogonadism Trial in Worldwide (Corifollitropin alfa, hCG)

Completed
Has Results
  • Hypogonadotropic Hypogonadism
  • Corifollitropin alfa
  • hCG
  • Curitiba, Brazil
  • +14 more
Feb 1, 2022

POTS - Postural Orthostatic Tachycardia Syndrome Trial in Malmö (Training program)

Active, not recruiting
  • POTS - Postural Orthostatic Tachycardia Syndrome
  • Training program
  • Malmö, Sweden
    Skånes Universitetssjukhus Malmö, Department of Cardiology
Dec 15, 2022

Epilepsy Trial in Worldwide (Brivaracetam)

Completed
Has Results
  • Epilepsy
  • Phoenix, Arizona
  • +183 more
Aug 16, 2021

Plaque Psoriasis Trial in Cleveland (Apremilast)

Completed
  • Plaque Psoriasis
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Nov 17, 2021

Heart Failure Trial in Stanford (Cardiac rehabilitation)

Not yet recruiting
  • Heart Failure
  • Cardiac rehabilitation
  • Stanford, California
    Stanford Health Care
Jan 13, 2023

ADHD, Dyslexia Trial in New Haven (Atomoxetine, Placebo)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • Dyslexia
  • New Haven, Connecticut
    Yale University School of Medicine
Oct 9, 2022

Transverse Maxillary Deficiency Trial in Kayseri (skeletal anchorage and rapid palatal expansion)

Completed
  • Transverse Maxillary Deficiency
  • skeletal anchorage and rapid palatal expansion
  • Kayseri, Kayseri̇, Turkey
  • +2 more
Jun 24, 2023

Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,

Recruiting
  • Oropharyngeal Cancer
  • Squamous Cell Carcinoma of the Oropharynx
  • Surgery
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
May 30, 2023

Knee Cartilage Lesion Trial in Wien (LNA043, to LNA043)

Terminated
Has Results
  • Knee Cartilage Lesion
  • LNA043
  • placebo to LNA043
  • Wien, Austria
  • +1 more
Oct 6, 2021

Subcutaneous HUMIRA Injection to Assess Adverse Events and

Recruiting
  • Crohn's Disease
    • Beijing, Beijing, China
    • +8 more
    Jan 12, 2023

    POTS Trial in Malmö (Training program)

    Withdrawn
    • POTS
    • Training program
    • Malmö, Sweden
      Skånes Universitetssjukhus Malmö, Department of Cardiology
    Nov 23, 2021

    Urolithiasis Trial in Assiut (PNL)

    Not yet recruiting
    • Urolithiasis
    • PNL
    • Assiut, Egypt
      Assiut University Hospital
    Aug 22, 2023

    Coronary Artery Disease, Drug Coated-balloon, Intravascular Ultrasound Trial in Valencia (Drug coated-balloon percutaneous

    Recruiting
    • Coronary Artery Disease
    • +5 more
    • Drug coated-balloon percutaneous coronary intervention.
    • Angiography-derived coronary physiology (IMRangio)
    • Valencia, Spain
      Hospital Universitario y Politécnico La Fe
    Oct 8, 2023

    Parapsoriasis Trial in United States (Apremilast, Placebo, Placebo-Apremilast)

    Completed
    Has Results
    • Parapsoriasis
    • Birmingham, Alabama
    • +25 more
    Mar 3, 2022